Do group visits improve HbA1c more than individual visits in patients with T2DM?
No Thumbnail Available
Authors
Meeting name
Sponsors
Date
Journal Title
Format
Article
Subject
Abstract
Do group visits improve HbA1c more than individual visits in patients with T2DM? Evidence-based answer: Yes. In patients with type 2 diabetes mellitus (T2DM), group visits led by health professionals or teams improved glycosylated hemoglobin (HbA1c) by 0.3% to 0.9% over usual care (strength of recommendation [SOR]: B, meta-analyses of randomized clinical trials [RCTs] with moderate to high risk of bias). Patients taking oral antidiabetic agents alone appear to benefit more than patients on insulin. Peer-led group visits likely have no effect (SOR: B, subgroup analysis within a meta-analysis). Treatment durations as long as 3 years are associated with larger decreases in HbA1c (by 0.25% per year) than treatment lasting less than a year (SOR: B, meta-analysis of RCTs involving patents with type 1 diabetes and T2DM). Patients with T2DM should be offered group visits for diabetes education when available (SOR: C, expert opinion).
Table of Contents
DOI
PubMed ID
Degree
Thesis Department
Rights
OpenAccess.
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.